Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Albendazole side effects in humans?Can grapefruit juice decrease lipitor's benefits?Abbvie humira patent cliff navigation success?The expiration date of the key patent for guselkumab?Tenofovir generic patent?
See the DrugPatentWatch profile for Daunoxome
Daunoxome (daunorubicin cholesterol sulfate) received FDA approval in 1987 [1].
FDA approval was for Kaposi’s sarcoma [1].
The FDA approval year remains 1987; any later changes (such as label updates, withdrawals, or availability issues) would be reflected in later FDA actions, but the approval date itself is tied to 1987 [1].
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013782